MALT1 is activated by doxorubicin and mediates therapy resistance in triple-negative breast cancer

被引：0
|
作者：
Beecher, Maria
Hu, Dong
Klei, Linda
Little, Jack
McAllister-Lucas, Linda M.
Lucas, Peter C.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-1762
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1762
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Triple-negative breast cancer and the potential for targeted therapy
    Jhan, Jing-Ru
    Andrechek, Eran R.
    PHARMACOGENOMICS, 2017, 18 (17) : 1595 - 1609
  • [22] Subtyping of Triple-Negative Breast Cancer: Implications for Therapy
    Abramson, Vandana G.
    Lehmann, Brian D.
    Ballinger, Tarah J.
    Pietenpol, Jennifer A.
    CANCER, 2015, 121 (01) : 8 - 16
  • [23] Progress in systemic therapy for triple-negative breast cancer
    Mo, Hongnan
    Xu, Binghe
    FRONTIERS OF MEDICINE, 2021, 15 (01) : 1 - 10
  • [24] Directed Therapy of Subtypes of Triple-Negative Breast Cancer
    Carey, Lisa A.
    ONCOLOGIST, 2010, 15 : 49 - 56
  • [25] Personalized targeted therapy in triple-negative breast cancer
    Ueno, Naoto T.
    ANNALS OF ONCOLOGY, 2015, 26 : 20 - 20
  • [26] New Vaccine Therapy for Triple-Negative Breast Cancer
    Harris, Paul E.
    Rubsamen, Reid
    CURRENT BREAST CANCER REPORTS, 2024, 16 (03) : 288 - 301
  • [27] Progress in systemic therapy for triple-negative breast cancer
    Hongnan Mo
    Binghe Xu
    Frontiers of Medicine, 2021, 15 : 1 - 10
  • [28] Mimicking the evolution of doxorubicin resistance in triple negative breast cancer
    Pearson, Kashenya
    Everett, Terrence
    Rorie, Checo J.
    CANCER RESEARCH, 2022, 82 (10)
  • [29] Triple-Negative Breast Cancer
    Winkeljohn, Debra L.
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2008, 12 (06) : 861 - 863
  • [30] Triple-Negative Breast Cancer
    Hudis, Clifford A.
    CANCER JOURNAL, 2010, 16 (01): : 10 - 11
12345